NZ307579A - Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses - Google Patents

Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses

Info

Publication number
NZ307579A
NZ307579A NZ307579A NZ30757996A NZ307579A NZ 307579 A NZ307579 A NZ 307579A NZ 307579 A NZ307579 A NZ 307579A NZ 30757996 A NZ30757996 A NZ 30757996A NZ 307579 A NZ307579 A NZ 307579A
Authority
NZ
New Zealand
Prior art keywords
plants
recombinant
obtaining
processes
derivatives produced
Prior art date
Application number
NZ307579A
Inventor
Philipee Lenee
Veronique Gruber
Sylvie Baudino
Bertrand Merot
Claude Benicourt
Claire Cudrey
Original Assignee
Parke Davis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis filed Critical Parke Davis
Publication of NZ307579A publication Critical patent/NZ307579A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6418—Fatty acids by hydrolysis of fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
    • C10L1/00—Liquid carbonaceous fuels
    • C10L1/02—Liquid carbonaceous fuels essentially based on components consisting of carbon, hydrogen, and oxygen only
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6454—Glycerides by esterification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Recombinant nucleotide sequences containing cDNA coding for preduodenal lipase, or any sequence derived from this cDNA, is used for transforming plant cells to obtain recombinant preduodenal lipase of polypeptide derivatives. The transformed plants, or plant extracts, or recombinant preduodenal lipase or polypeptide derivatives may be useful for food or medicine.
NZ307579A 1995-04-20 1996-04-19 Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses NZ307579A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9504754A FR2733249B1 (en) 1995-04-20 1995-04-20 RECOMBINANT DOG GASTRIC LIPASE AND POLYPEPTIDES DERIVED BY PLANTS, PROCESSES FOR OBTAINING SAME AND USES THEREOF
PCT/FR1996/000606 WO1996033277A2 (en) 1995-04-20 1996-04-19 Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses

Publications (1)

Publication Number Publication Date
NZ307579A true NZ307579A (en) 1999-11-29

Family

ID=9478306

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ307579A NZ307579A (en) 1995-04-20 1996-04-19 Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses

Country Status (26)

Country Link
US (2) US6573431B1 (en)
EP (1) EP0822988B1 (en)
JP (2) JP4077875B2 (en)
KR (1) KR19990007901A (en)
CN (1) CN1185178A (en)
AR (1) AR004482A1 (en)
AT (1) ATE313632T1 (en)
AU (1) AU718905B2 (en)
BG (1) BG64320B1 (en)
BR (1) BR9608011A (en)
CA (1) CA2218418A1 (en)
CZ (1) CZ330997A3 (en)
DE (1) DE69635611T2 (en)
ES (1) ES2256858T3 (en)
FR (1) FR2733249B1 (en)
HU (1) HUP9801438A3 (en)
IL (1) IL117955A0 (en)
MX (1) MX9707973A (en)
NZ (1) NZ307579A (en)
PL (1) PL186586B1 (en)
RU (1) RU2235129C2 (en)
SK (1) SK140197A3 (en)
TR (1) TR199701207T1 (en)
UA (1) UA73267C2 (en)
WO (1) WO1996033277A2 (en)
ZA (1) ZA963146B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2759857B1 (en) * 1997-02-27 1999-04-30 Biocem NEW USES OF MALE STERILITY IN PLANTS
FR2774379B1 (en) * 1998-01-30 2002-03-29 Groupe Limagrain Holding PROCESS FOR THE PRODUCTION OF ALPHA 1-ANTITRYPSIN AND ITS VARIANTS BY PLANT CELLS, AND PRODUCTS CONTAINING THE ALPHA-ANTITRYPSIN OBTAINED THEREBY
FR2777155B1 (en) 1998-04-09 2000-06-23 Meristem Therapeutics SEEDS AND PLANTS OF WHICH THE GERMINATING POWER IS DESTROYED BY THE TOTAL OR PARTIAL ABSENCE OF AT LEAST ONE ENERGY RESERVE ESSENTIAL TO GERMINATION
FR2810667B1 (en) * 2000-06-23 2004-09-03 Warner Lambert Co PROCESS FOR ISOLATING AND PURIFYING PROTEIN, AND PROTEIN OBTAINED
US7288124B2 (en) 2004-09-08 2007-10-30 L'oreal S.A. Heteroaromatic binuclear black direct dyes
US20110070201A1 (en) 2005-07-18 2011-03-24 Protalix Ltd. Mucosal or enteral administration of biologically active macromolecules
FR3036119B1 (en) * 2015-05-15 2019-04-19 Universite De Picardie Jules Verne PROCESS FOR PRODUCING PROTEINS OF INTEREST FROM A PLANT STRUCTURE
CN112480233B (en) * 2020-12-14 2022-05-27 上海交通大学 Bioactive peptide IAHPKLGKRIR, and preparation method and application thereof
CN115669542B (en) * 2022-11-04 2023-08-25 西北农林科技大学 Plant tissue culture detoxification method

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3150988A1 (en) * 1980-12-30 1982-08-05 Institut Français du Pétrole, 92502 Rueil-Malmaison, Hauts-de-Seine COMBUSTIBLE COMPOSITIONS CONTAINING ALCOHOLS AND FATTY ACID ESTERS AND IN PARTICULAR USE THAN DIESEL FUELS
US5538868A (en) * 1984-02-08 1996-07-23 Cetus Oncology Corporation Recombinant ricin toxin fragments
GB8421210D0 (en) * 1984-08-21 1984-09-26 Celltech Ltd Polypeptide and polypeptide composition
GB2188057B (en) * 1986-02-04 1990-03-07 Inst Penyelidikan Minyak Kelap Transesterification of fats and oils
FR2603804B1 (en) * 1986-09-17 1989-10-27 Jouveinal Sa LIPASES AND LIPASIC EXTRACTS, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN THERAPEUTICS
WO1991006661A1 (en) * 1989-11-03 1991-05-16 Opta Food Ingredients, Inc. Lipase-catalyzed in situ generation of mono- and di-glycerides
IL97645A (en) * 1990-03-23 1997-03-18 Gist Brocades Nv Production of enzymes in seeds and their use
DK162790D0 (en) * 1990-07-06 1990-07-06 Novo Nordisk As PLANT CELL
DK0596979T3 (en) * 1991-08-01 2002-05-13 Large Scale Biology Corp Plant virus recombinant nucleic acids
FR2683549B1 (en) * 1991-11-13 1994-11-18 Jouveinal Inst Rech NUCLEIC ACIDS ENCODING FOR RABBIT GASTRIC LIPASE AND POLYPEPTIDE DERIVATIVES, THEIR USE IN THE PRODUCTION OF SUCH POLYPEPTIDES, AND PHARMACEUTICAL COMPOSITIONS BASED THEREON.
FR2699179B1 (en) * 1992-12-16 1995-01-06 Jouveinal Inst Rech Nucleic acids coding for dog gastric lipase and polypeptide derivatives, their use for the production of these polypeptides, and pharmaceutical compositions based thereon.
IS4130A (en) * 1993-03-01 1994-09-02 Ab Astra New polypeptide
FR2722798B1 (en) * 1994-07-25 1996-09-13 Toulouse Inst Nat Polytech 1PROCESS FOR THE PRODUCTION OF OLEAGINOUS FATTY ACIDS

Also Published As

Publication number Publication date
HUP9801438A3 (en) 2000-11-28
FR2733249B1 (en) 1997-06-06
WO1996033277A3 (en) 1996-11-28
US20040072317A1 (en) 2004-04-15
MX9707973A (en) 1998-08-30
ZA963146B (en) 1997-01-22
EP0822988A2 (en) 1998-02-11
KR19990007901A (en) 1999-01-25
FR2733249A1 (en) 1996-10-25
UA73267C2 (en) 2005-07-15
TR199701207T1 (en) 1998-02-21
DE69635611T2 (en) 2006-09-14
CN1185178A (en) 1998-06-17
JPH11504207A (en) 1999-04-20
PL322874A1 (en) 1998-03-02
BR9608011A (en) 1999-01-05
PL186586B1 (en) 2004-01-30
ES2256858T3 (en) 2006-07-16
US6573431B1 (en) 2003-06-03
AU5696796A (en) 1996-11-07
AU718905B2 (en) 2000-04-20
BG64320B1 (en) 2004-09-30
CZ330997A3 (en) 1998-03-18
BG101959A (en) 1998-07-31
SK140197A3 (en) 1998-07-08
IL117955A0 (en) 1996-08-04
AR004482A1 (en) 1998-12-16
JP2007325590A (en) 2007-12-20
HUP9801438A2 (en) 1998-10-28
JP4077875B2 (en) 2008-04-23
EP0822988B1 (en) 2005-12-21
DE69635611D1 (en) 2006-01-26
CA2218418A1 (en) 1996-10-24
ATE313632T1 (en) 2006-01-15
RU2235129C2 (en) 2004-08-27
WO1996033277A2 (en) 1996-10-24

Similar Documents

Publication Publication Date Title
AU7659298A (en) Recombinant lactoferrin, methods of production from plants and uses
HU9603170D0 (en) Dna sequences coding for enzymes capable of facilitating the synthesis of linear alfa-1,4 glucans in plants, fungi and microorganisms
MY101972A (en) Primate interleukin - 4
DE10075019I2 (en) New proteins with TNF inhibitory activity and their production.
IL111181A0 (en) Stem cell proliferation factor, its preparation, purification and uses
NZ514025A (en) Compositions and methods for the modification of gene transcription
IL195812A0 (en) Human tslp dna and polypeptides
AU6929794A (en) Regulation of plant growth
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
NZ307579A (en) Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses
ATE113982T1 (en) BRANCHING ENZYME AND ITS USE.
IL141869A0 (en) Mammalian transforming growth factor beta-9 (ztgfss9)
HU895788D0 (en) Process for producing peptides and medical products containing them
ATE182900T1 (en) MUTATED FORM OF THE BETA-AMYLOID PRECURSOR PROTEINE GENE
GB9323225D0 (en) Novel plant enzyme
ATA901196A (en) USE OF ACTIVATED PROTEIN C FOR PRODUCING A PHARMACEUTICAL PREPARATION
WO1991011462A3 (en) Merosin, nucleic acids encoding, fragments and uses thereof
CA2151381A1 (en) Recombinant dog gastric lipase and pharmaceutical compositions
GB9517674D0 (en) Plastid inner envelope membrane targeting polypeptides;manufacture and use thereof
AU7452187A (en) New human lymphotoxin (TNF-beta) polypeptides their prepartion and use
DE3781832D1 (en) C-TERMINAL-ALPHA-AMIDATING ENZYME AND METHOD FOR THE PRODUCTION AND USE THEREOF.
KR100256319B1 (en) Stem cell proliferation factor
EP0290029A3 (en) (19-alanine) calcitonin
UA22019A (en) Method for determination of death-cup poison cytotoxicity

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: MERISTEM THERAPEUTICS SA, FR

Free format text: OLD OWNER(S): PARKE-DAVIS

RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired